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Abstract 
 
Background: Non-speech oro-motor exercises (NSOMExs) are described in speech 
and language therapy (SLT) manuals, and are thought to be much used in acquired 
dysarthria intervention, though there is no robust evidence of an influence on speech 
outcome.  Opinions differ as to whether, and for which dysarthria presentations, 
NSOMExs are appropriate. 
Aims: The investigation sought to collect development phase data, in accordance with 
the Medical Research Council evaluation of complex interventions. The aims were to 
establish the extent of NSOMExs use in acquired disorders, the exercise regimes in 
use for dysarthria, with which dysarthric populations, and the anticipated clinical 
outcomes. A further aim was to determine the influencing rationales where NSOMExs 
were or were not used in dysarthria intervention. 
Methods & Procedures: SLTs throughout Scotland, Wales and Northern Ireland, 
working with adult acquired dysarthria, were identified by their service heads. They 
received postal questionnaires comprising 21 closed and two open questions, covering 
respondent biographics, use of NSOMExs, anticipated clinical outcomes, and practice 
influencing rationales. 
Outcome & Results: One hundred and ninety one (56% response) completed 
questionnaires were returned. Eighty-one per cent of respondents used NSOMExs in 
dysarthria. There was no association with years of SLT experience. Those who used 
and those who did not use NSOMExs provided similar influencing rationales, 
including evidence from their own practice, and Higher Education Institute (HEI) 
teaching.  More experienced SLTs were more likely than those more recently 
qualified to be guided by results from their own practice. Input from the attended HEI 
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was more influential for those less experienced than for those more experienced. 
Clinical outcome aims were not confined to speech, but included also improvements 
in movement, sensory awareness, appearance, emotional status, dysphagia and 
drooling. NSOMExs were used with many neurological disorders, especially stroke, 
all dysarthria classes, especially flaccid, and all severity levels. Tongue and lip 
exercises were more frequent than face, jaw and soft palate. The most common 
regimes were 4-6 repetitions of each exercise, during three practice periods daily, 
each of 6-10 minutes. 
Conclusions & Implications: NSOMExs are a frequent component of dysarthria 
management in the UK devolved government countries. This confirmation, along with 
the details of SLT practice, provides a foundation for clinical research which will 
compare outcomes for people with dysarthria, whose management includes and does 
not include NSOMExs. SLT practice may be guided by evidence that speech outcome 
is or is not affected by NSOMExs  
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Introduction 
Many dysarthria treatment manuals include movement exercises for the oral speech 
muscles, principally the tongue and lips (Robertson and Thomson 1987, Swigert 
1997, Kaye 2000, Sugden –Best 2002). These non-speech oro-motor exercises 
(NSOMExs), also known as speech mechanism exercises (Hustad and Weismer 
2007), or subsumed within the broader category of neuromuscular treatments (Clark 
2003), appear to have a long tradition in speech and language therapy (SLT) practice.  
Publications in English, recommending and explaining NSOMExs for people with 
acquired dysarthria, date from around 1940 (Robbins 1940, Froeschels 1943). As is 
the case for many SLT treatments, no robust evidence base supports the use of 
NSOMExs in acquired dysarthria (Clark 2003). Moreover, there is ongoing debate as 
to whether the movement basis for such exercises is relevant to speech (Weismer 
2006).  
 
The rationale for NSOMExs is that these will increase levels of tension, endurance 
and power of weak muscles, for example of the tongue (Clark 2003). Establishing that 
weakness is actually present is seriously hindered by its clinical evaluation being 
almost always subjective, lacking normative reference data and demonstrated 
reliability, and involving activities which are not used in speech, such as pushing the 
tongue into the cheek,. An additional reservation is that physiological capacity in 
healthy individuals far exceeds speech requirements, so strength may not be a useful 
measure for predicting speech capacity (Kent 2009). Research using laboratory 
procedures for example the Iowa Oral Performance Instrument (Blaise Medical Inc), 
indicates that significant deficit in muscle strength may accompany normal speech 
(Rosenbek and Jones 2009). Wieismer’s review (2006) of the literature shows little or 
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no relationship between NSOM performance and speech severity, thus demonstrating 
that extent of speech involvement cannot be predicted from weakness assessment. 
Therefore even if weakness can be reliably demonstrated in speech musculature, the 
assumption that this causes dysarthria is not valid.  
 
Those who advocate widespread use of NSOMExs think that they form an important 
foundation for speech, and lead to enhancement of speech (Dworkin 1991, Kearns and 
Simmons 1998).  Speech is regarded as a motor skill which can be reduced to 
components, as distinct from the view that speech is a highly specific activity, in 
respect of its motor control. Froeschels (1943), one of the early proponents of this 
approach, cautioned against initiating speech exercises in dysarthria ‘before the best 
possible training of the muscles involved has been achieved’, because to contravene 
this ‘rule’ ‘might increase the unbalanced condition’ (Froeschels 1943, P313). Some 
authors adopt a more cautious approach, believing NSOMExs to be relevant only to 
the most severely impaired patients (Darley, Aronson and Brown 1975), and used ‘as 
a last resort’ (Rosenbek and Jones 2009, P281). Rosenbek and Jones (2009) conclude 
that oral non- speech drills cannot be justified: ‘Practice wagging your tongue and this 
skill will improve…..but speech will be uninfluenced.’ (P271). 
 
Some writers judge NSOMExs to be appropriate only for particular classes of 
dysarthria, but there is no consensus as to the relevant diagnostic groups. For Duffy 
(2005), these are flaccid, spastic, unilateral upper motor neurone and hypokinetic 
dysarthrias, and within these, only for occasional cases. Zraick and LaPointe (2009) 
include hyperkinetic conditions. Murdoch, Ward and Thodoros (2009) exclude  
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spastic dysarthria,  because of the increased muscle tone which may be exacerbated 
by quick movements, and Rosenbek and Jones (2009) exclude hyperkinetic, 
hypokinetc and ataxic groups, because of disco-ordination and impaired timing.  
Cannito and Marquardt (2009) however include ataxic dysarthria, where significant 
hypotonia and weakness are present. 
 
Intervention studies where NSOMExs have been used are few, and provide no 
conclusive support for their place in dysarthria management. Two studies report on 
small groups of participants who had dysarthria resulting from stroke.  Ray (2002) 
demonstrated significant increases in single word intelligibility, but not in sentence or 
conversational intelligibility, following a programme of NSOMExs.  Robertson 
(2001) reported score gains on a dysarthria assessment, in the majority of participants, 
following a therapy programme which included both oro-motor exercises and speech 
practice. The contribution of non-speech exercises to this outcome cannot be 
determined.     
 
A questionnaire study carried out in the USA by Gerratt, Till, Rosenbek, Wertz and 
Boysen (1991) showed that non speech manoeuvres are a frequent and valued 
component of dysarthria assessment. NSOMExs are reported to be currently in wide 
clinical use with the dysarthria population (Duffy 2007, Palmer and Enderby 2007), 
but there are no published data on for what reasons NSOMExs are used, how 
extensive this use is, and in what circumstances. Between 71.5% and 85% of 
clinicians use NSOMExs in therapy aimed at improvement of children’s speech, and 
here too there is no demonstrated therapeutic effectiveness (Lof 2008).   Despite the 
reservations of some leading authorities, and the lack of evidence, clinicians appear to 
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believe NSOMExs are beneficial, perhaps giving undue credence to literature which 
confirms their own hypotheses (McCauley 2001). In all clinical fields, published 
protocols for intervention, which busy therapists can use without the need for time 
demanding preparation, tend to be well received, and many exercise lists are readily 
available. Clinicians will be guided also by results of their own practice, and are likely 
to use techniques they consider to have been beneficial to individual patients.  
 
Because of their apparent pervasive use in acquired dysarthria, Duffy (2007) rates the 
resolution of the debate about the efficacy of oro-motor exercises as an intervention 
research priority. In the long-term, the central research question is whether outcome 
differs for those dysarthric patients who receive NSOMExs as part of their 
intervention, and those who do not. Consistent with the development phase in the 
Medical Research Council recommended phases of evaluation of complex 
interventions (Craig, Dieppe, Macintyre, Mitchie, Nazareth and Petticrew 2008), we 
sought to establish the extent of, and rationale for, use of NSOMExs, the exercise 
regimes in use, the dysarthric populations with whom the exercises are used, and the 
anticipated clinical outcomes. The investigation was concerned with SLTs’ use of 
active exercises for the oral speech organs, and did not include the use of passive 
exercises, for example stretching carried out by the clinician, massage, tapping or 
vibration, or the application of physical agents, such as cold or heat (Clark 2003). 
Syllable repetition quasi-speech tasks (alternatively known as diadochokinesis, or 
alternating motion rate) were also excluded from study, as were exercises for the 
phonatory and respiratory mechanisms. 
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Method   
Through personal contact with all relevant SLT service heads, throughout Scotland, 
Wales and Northern (N) Ireland (the three countries of the United Kingdom with 
devolved governments), the numbers of SLTs whose remit included adults with 
acquired dysarthria was established. Individual questionnaires for these SLTs, 
information about the Project and postage paid envelopes, for return to the research 
team were supplied to the service heads, for distribution. The information explicitly 
stated that speech difficulty resulting from surgery or other treatments for cancer was 
not relevant. Inducements were not offered. No identifying information was requested 
and geographical anonymity was ensured by the removal of questionnaires from 
return envelopes, prior to being passed for processing. An additional letter and 
response form invited respondents to signal their interest in future plans for a clinical 
investigation, using a separate response addressed envelope. A questionnaire return 
date of around three weeks was requested. Just prior to this date, and also two weeks 
later, e mail reminders were sent to the distributors.  
 
Questions on the following were included in the questionnaire: 
Biographical: years since SLT qualification; years of practice; higher education  
institution (HEI) at which SLT qualification was obtained; current main work settings. 
Use of exercises: whether NSOMExs are or would be used in management of 
dysarthria, apraxia of speech and dysphagia (the present/conditional tense verb aimed 
to exclude responses where NSOMExs may have been used previously but are no 
longer used). 
Dysarthria management rationale: influencing factors for use of NSOMExs, and 
clinical outcomes anticipated; influencing factors for not using NSOMExs. 
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For those responding they do or would use NSOMExs in dysarthria: 
Dysarthria management categories: with which neurological diagnostic groups, 
dysarthria types, severities and stages (definitions were supplied for severities and 
stages: see appendix 1a and 1b). 
Dysarthria management regime: involving which anatomical structures, typical 
recommendations re number of exercise repetitions, frequency and length of practice; 
sources of exercises; use of written information and sources for this. 
 
There were 21 closed questions (reduced to eight for respondents who did not use 
NSOMExs), specifying yes/no responses, or selection from lists, some of which 
required one option, and others selection of all options applicable. Additionally there 
were two open questions (HEI attended, and clinical outcome(s) anticipated). Piloting 
of a draft questionnaire indicated a completion time of between five and 15 minutes. 
 
Responses to closed questions, and the open question on HEI attended, were entered 
on an SPSS (version 16) database. Descriptive statistics were calculated for all 
questions, and chi-square analyses were carried out to examine associations between 
some variables. The respondent population was fairly equally divided between 10 or 
fewer years of experience and 11 or more years, and in examining association 
between experience length and practice influencing variables, two groups were 
accordingly formed. Exact rather than asymptotic significance was calculated for 
examination of the group who did not use NSOMExs, as this numbered less than 50. 
Responses to the open question on the clinical outcomes aimed for were listed and 
examined for recurring themes.  
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Results 
A total of 341 questionnaires were sent to service heads (Scotland: 208, Wales: 99, N 
Ireland: 34), in response to the staffing estimates received. One hundred and ninety-
one (56%) completed questionnaires were returned. 
Biographical details: Years since qualification and years of experience were very 
similar, so only experience years are reported. Thirty per cent of respondents had 11-
20 years of experience. This was the highest response category, followed by 21 or 
more years (23%). The remaining categories of 1-2, 3-5 and 6-10 years were 
respectively 14%, 18% and 16%, so almost half of the responding dysarthria 
workforce had 10 or fewer years of experience. Seventy-two per cent of respondents 
had obtained their qualification from one of the four HEIs offering courses 
preparatory to entry to the SLT profession in the distribution area. Most other UK 
institutions which provide courses were represented, as were a few non-UK 
institutions.  Main work settings were acute care (60%), out patient facility (51%), in 
patient rehabilitation (50%), domiciliary (46%), care home (34%), hospital day care 
(25%) and hospital long term care (19%). Many respondents selected more than one 
category. 
 
Use of exercises:  
Eighty-one per cent of respondents used NSOMExs in dysarthria, and 19% did not. 
There was no association with years of SLT experience (χ2 (4) = 2.60, n.s). Use of 
NSOMExs in dysarthria was examined in relation to the four main HEIs attended. 
There was no association between use and HEI (χ2 (3) = 0.34, n.s). Use of NSOMExs 
in dysarthria was further examined in relation to main work settings. A significant 
association was present for in-patient rehabilitation (χ2 (1) = 3.91, p < 0.05), and a 
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strong trend was present in respect of domiciliary (χ2 (1) = 3.18, p  = 0.07). Those 
SLTs with in-patient rehabilitation as main work setting were more prone to use 
NSOMExs than those for whom this was not a main work setting, and there was an 
indication that there may be a similar relationship in respect of domiciliary work.  
Acute care and out-patient facilities as main work settings were not associated with 
use or otherwise of NSOMExs (acute care: χ2 (1) = 0.16, n.s; out-patient: χ2 (1) = 
1.04, n.s.). 
 
Eighty seven per cent of respondents used NSOMExs with dysphagia, 10% did not 
and 3% did not respond. For apraxia of speech (AOS), 38% used NSOMExs, and 
62% did not.  Of those who used NSOMExs in dysarthria, 94% did so also in 
dysphagia, and 42% in AOS. Seventy two per cent of those who did not use 
NSOMExs in dysarthria did use them in dysphagia and 17% in AOS. Cross 
tabulations of NSOMExs use in dysarthria with  dysphagia and AOS are given in 
table 1. 
table 1 about here 
 
Dysarthria management rationale 
Agreement with 12 options offered as rationales for using NSOMExs ranged from 8 - 
63% (see figure 2). Many respondents selected several options. The main influences 
on decision to use NSOMExs in dysarthria were evidence from own practice, and 
discussion with colleagues, both cited by over 60%. Other common influences, all 
with over 40% response, were patient expectations, HEI SLT education, SLT 
tradition, observation of other SLTs, and lack of evidence regarding alternative 
approaches.  
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Agreement with ten options offered as rationales for not using NSOMExs ranged 
from 8-78%.(see figure 1).  Many respondents selected several options. The main 
influences on decision not to use exercises in dysarthria were lack of published 
evidence, and evidence from own practice, both cited by over 70%. Other common 
influences, all with over 40% response, were discussion with colleagues, HEI SLT 
education, postgraduate education, and relevant reading. 
 
figure 1 about here 
 
Some commonality between the most frequent rationales for using and not using 
NSOMExs was evident.  Associations between years of experience and evidence from 
my own practice, as a reason for both using (χ2 (1) = 6.25, p = 0.01), and not using (χ2 
(1) = 6.89, p = 0.01) NSOMExs were significant with more experienced SLTs more 
likely than more recently qualified respondents to be influenced by results from their 
own practice. Association between HEI SLT education and years of experience was 
significant for those not using NSOMExs (χ2 (1) = 7.84, p < 0.01), and for those using 
NSOMExs there was a strong trend towards association (χ2 (1) = 3.09, p = 0.08), 
suggesting greater influence from the attended HEI for less than for more experienced 
respondents. 
 
Clinical outcomes 
An open question invited participants to indicate the clinical outcomes they aimed to 
achieve by using NSOMExs with dysarthric adults. Responses were received from 
95% (146) of NSOMExs users, providing a total of 247 statements. Responses were 
first examined by MM.  In discussion with CM, six main recurring themes were 
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discriminated as improvement targets. These were assigned broad labels of speech 
(including also reference to intelligibility and articulation); movement (reference to 
strength, tone, rate, range, direction and control); sensory awareness (including also 
reference to proprioception and feedback); appearance (including also reference to 
facial symmetry and expression); emotional status (reference to motivation, morale, 
mood, quality of life and confidence); dysphagia and drooling (reference to eating, 
drinking and saliva control). Additional miscellaneous comments included objectives 
of reduction in oedema, and promotion of oral hygiene. MM and CM independently 
categorised responses according to these themes.  Level of agreement was 98%. The 
few cases of disagreement were resolved by discussion. Improvement in speech was 
the most common theme, but for 41% of those who responded to this question, no 
reference was made to speech, intelligibility, or articulation.  Clinical outcome aim 
data are given in table 2, with illustrative examples.  
 
table 2 about here  
 
Dysarthria management categories 
NSOMExs were used with all ten neurological conditions included in the 
questionnaire, all eight dysarthria types, all five levels of severity, both acute and 
chronic stages, and also improving, stable and progressive presentations.  
By far the most common neurological condition with which NSOMExs were used 
was stroke (95%), followed by traumatic brain injury (58%), and Parkinson’s 
disease/Parkinsonism (47%). All other options were selected by fewer than 30% (see 
figure 2). Of dysarthria types, flaccid (87%) was distinctly the most common 
category. Hypokinetic, mixed and spastic were all above 40% (see figure 3). Ninety- 
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seven per cent of respondents who used NSOMExs did so with people at acute 
(defined as less than three months duration) and 70% at chronic (duration of three 
months or longer) stage. NSOMExs were used with those whose dysarthria was 
considered improving (94%), stable (60%) and progressive (35%) (see appendix 1a 
for definitions). As regards severity levels (see appendix 1b for definitions), 
NSOMExs were used with moderate (87%), severe (86%), mild (63%), profound 
(51%) and anarthria (38%). 
 
figures 2 and 3 about here 
 
Dysarthria management regimes 
NSOMExs for tongue, lips, face, jaw and soft palate were used. The frequency of 
exercise use (always, very often, often, occasionally, never) for each structure is 
shown in figure 4. All respondents used exercises for lips and tongue, and always or 
very often was the response category in at least 80% of instances. For face, jaw and 
soft palate these frequencies of involvement were all less than 30%. The most 
common response category was occasionally for jaw and soft palate, and for face, 
often .For these three structures, small numbers of respondents (<15%) never gave 
exercises.  
 
figure 4 about here 
 
There was much variation in advice typically given to patients about numbers of 
repetitions of each exercise and number and length of practice periods each day (see 
figure 5a-c). The most frequent regimes were 4-6 repetitions of each exercise, during 
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three practice periods daily, each of 6-10 minutes duration. Respondents drew these 
exercises from many sources, particularly therapy resource manuals (88%), materials 
produced by their departments (77%), discussion with other SLTs (55%) and text 
books (54%). For all but one respondent, written information and instructions about 
the exercises were given to patients, most often obtained from therapy resource 
manuals (84%) and materials produced by their departments (77%). 
 
figure 5 a-c about here 
 
Interest in future research 
One hundred and twenty three respondents (64%) expressed interest in being 
informed of future developments in our NSOMExs research. 
 
Discussion 
The 56% response rate for this study is well in advance of the 35% return considered 
acceptable for postal questionnaires (Jackson and Furnham 2000). In the study of 
communication disorders, a rate below 50% is noted to be typical (Pring 2005).  
 
This survey was undertaken as a basis for future research evaluating clinical outcomes 
in relation to use of NSOMExs. It was established that such exercises are a frequent 
component of management of dysathria in the devolved government countries of the 
UK, and are equally used by both recently qualified therapists and by those with much 
experience, regardless of the HEI attended. If the investigation had shown that these 
exercises were little used, the foundation for clinical trial research might be 
questioned. 
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 Factors influencing practice 
In the absence of evidence from controlled experimental work, expert opinion may be 
cited as evidence to support practice, albeit at the lowest level (Scottish Intercollegiate 
Guidelines Network 2008a).The literature referred to in the Introduction to this paper 
includes such expert opinion, encouraging, but also opposing, the use of NSOMExs. 
Rosenbek and Jones (2009) believe that even uncontrolled descriptive studies of an 
individual clinician’s treatment contribute to evidence. The main reason respondents 
gave for using NSOMExs, cited by 64%, was evidence from their own practice, 
indicating that there is a widely held belief that NSOMExs have been of value to 
patients.  However this same explanation was forwarded as a rationale by a sizeable 
majority (70%) of those who elected not to use exercises. In both cases experienced 
SLTS were more likely to note this influence than those working for ten or fewer 
years. Thus there is no experienced practitioner consensus which might be forwarded 
as guidance for practice.  
 
What is taught in HEIs to students in training should be a powerful influence on 
professional practice. Over 40% of those both using and not using NSOMExs were 
influenced by their SLT education. It is only within the last decade that the necessity 
of a strong evidence base for practice has been emphasised in the allied health 
professions, so SLTs who graduated within the last 10 years might reasonably be 
expected to have a more cautious approach to NSOMExs, as reference would be made 
to the lack of evidence in their HEI dysarthria teaching. The data do not support this. 
However for both those using and for those not using NSOMExs, there were 
indications that  HEI education was more influential for those working for ten or 
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fewer years, than for more experienced clinicians. HEIs might differ in the teaching 
emphasis, or the recommendations made, regarding NSOMExs in dysarthria, but the 
decision to use NSOMExs did not appear to be affected by the HEI attended.  
 
Apraxia of speech and dysphagia 
Muscular weakness, whereby ability to exert force is reduced, is a common feature of 
dysarthria, associated with flaccid and spastic classes (Palmer and Enderby 2007), the 
latter including unilateral UMN lesions, according to some classifications. A key 
distinction between dysarthria and apraxia of speech (AOS) is that in AOS the speech 
disorder exists in the absence of detectable weakness or hypertonicity (Weismer 
2007). A common diagnostic criterion for AOS is that strength of articulators is 
deemed to be within normal limits (McNeil, Robin and Schmidt 2009).  Because AOS 
is understood to be a speech programming disorder, Rosenbek and Jones (2009) 
describe the use of NSOMExs in AOS treatment as ‘nonsensical’ (Rosenbek and 
Jones 2009, P271), though  Duffy (2005) notes that sometimes they are used with the 
aim of improving ability to plan or programme movements.. NSOMExs use with the 
AOS population was not anticipated in this survey. Nevertheless 38% of respondents, 
including some who did not use NSOMExs in dysarthria, carried out NSOMExs with 
AOS patients. Dworkin, Abkarian and Johns (1988) included intensively practised 
oro-neuromotor control activities, such as raising and lowering the tongue, plus 
speech activities, in a treatment progaramme for a patient with AOS.Improvements in 
both movement and speech were evident, but as in Robertson’s (2001) dysarthria 
study, it is not possible to conclude whether the NSOMExs did or did not contribute 
to the change.  
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As with  dysarthria, empirical support for use of NSOMExs  in dysphagia is very 
limited  (Clark 2003). It was anticipated that those using NSOMExs in dysarthria 
would do so in dysphagia also, given their common co-occurrence in disorders such 
as stroke and Parkinson’s disease. The frequency of use of NSOMExs in dysphagia 
was 87%, thus a little higher than in dysarthria. Seventy two per cent of those who did 
not use NSOMExs in dysarthria regarded them as appropriate to dysphagia. 
Dysarthria was the focus of the survey, so guiding rationale for NSOMExs in 
dysphagia was not questioned, and given the general nature of the question it is 
possible that respondents did not confine their responses to neuro-muscular dysphagic 
disorders. 
 
Clinical outcomes 
Most respondents who used NSOMExs provided at least one statement indicating 
what they aimed to achieve by this practice. Reference to improved speech status was 
the most commonly occurring theme, but many respondents made no mention of 
speech, confining themselves to aspects of muscles and movements, sensation, and 
appearance. There was also a belief in some respondents that psychological benefits 
might arise from NSOMExs, for example relating to motivation and morale. 
Furthermore although the question specified dysarthria context, responses included 
eating and drinking goals. It is thus clear that therapists have many and varied goals 
when using exercises in dysarthria. It may be that some of these additional objectives 
underlie the incorporation of NSOMEXs in AOS management. 
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Dysarthia categories 
Given the conflicting advice about the types of dysarthria for which NSOMExs might 
be suitable, it is not surprising that all dysarthria categories were represented in the 
responses.  Authors who think NSOMExs may have a place in dysarthria management 
are in agreement only over the flaccid class. The response frequency (87%) for that 
diagnostic group was around double that of the next most accepted classes 
(hypokinetic, mixed and spastic). This may reflect awareness of endorsement in 
relevant literature, or previous experience with patients. Where flaccid dysarthria 
results from myasthenia gravis there is consensus in the literature that NSOMExs are 
explicitly contradicted, because of the fatigue which is characteristic of the disease. 
However a small number (7%) of the respondents who used NSOMExs did so with 
myasthenia gravis patients.  
 
The number of respondents selecting hyperkinetic dysarthria was low (15%). There is 
little  published speech research involving hyperkinetic patients, despite this type of 
dysarthria being reported as the most frequently occurring presentation of all the 
single, uncomplicated classes (Duffy 2005). Therefore it is likely that respondents 
would have experience with hyperkinetic patients. SLTs may be influenced by the 
many authors who consider NSOMExs to be inappropriate for this group, or again 
their own results may guide their decision.     
 
NSOMExs are regarded by respondents as suitable in a wide range of neurological 
disorders and diseases, but stroke is remarkable in that only 5% of those using 
NSOMExs did not include stroke cases. Stroke is the most common cause of severe 
disability in adults (Scottish Intercollegiate Guidelines Network 2008b) and dysarthria 
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is present in 8-30% of stroke patients, sometimes as the only clinical manifestation 
(Urban et al 2006). Therefore for SLTs who work with dysarthria, stroke is likely to 
be one of the most frequently encountered neurological disorders. Stroke has been 
associated with all forms of dysarthria, accounting for 22% of dysarthria cases 
according to Duffy’s (2005) audit data. The questionnaire data do not permit 
extrapolation as to whether and how use of NSOMExs varied with the stroke 
dysarthric diagnostic class. However it is interesting that despite Duffy’s (2005) data 
showing 90% of cases of uniUMN dysarthia to have vascular aetiology, only 30% of 
respondents who use NSOMExs did so with that group. Although its occurrence is 
reported to be equivalent to flaccid, spastic and hypokinetic classes, all at around 9%  
of total dysarthria  assessments (Duffy 2005),  uniUMN dysarthria is usually 
considered to be mild and of short duration (Duffy 2005). However, given that 63% of 
respondents using NSOMExs do so with mild degrees of dysarthria, and 95% with 
patients thought to have improving presentation, a higher response might have been 
expected for this dysarthria class.  
 
Some authors see a place for NSOMExs with only the most severe patients. In this 
investigation, the most severe levels (profound and anarthria) attracted the lowest 
positive responses. How severity is defined is relevant here, and for the purposes of 
the questionnaire for both of these categories, speech would require to be augmented 
or replaced by other forms of communication. The lower response relative to less 
severe categories, may indicate a shift of emphasis away from speech management, in 
favour of alternative or augmentative approaches. Nevertheless even where patients 
have no useful speech (anarthria), 38% of relevant respondents use NSOMExs, 
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suggesting a belief that the practice of NSOMExs will facilitate the return of 
functional speech. 
 
Exercise regimes 
Where there is a lack of published evidence to guide practice, therapists are likely to 
adopt differing regimes. This was evident in the numbers of repetitions, and 
frequencies and durations of practice periods. . Although the most common schedules  
typically used were  4- 6 repetitions per exercise, three practise periods each day, and 
each period of  6-10 minutes, there were many examples of more limited and more 
extensive practice. A few respondents indicated that they encouraged patients to 
practice for as long and as often as they wished to. Hageman (2009) contends that 
NSOMExs tend not to capture the elements of strengthening activity which are 
necessary to generate neural adaptation for speech movements. Intensive training, 
with progressively increasing demands, is thought necessary for motor learning 
(Rosenbek and Jones 2009). According to Clark (2003) increases in strength, 
endurance and power require overload, that is the taxing of the muscles beyond their 
typical workload, and improvement in strength and endurance cannot be expected 
when exercise is discontinued before reaching the point of fatigue. Several authors 
specify more practice than that typically used by the respondents. Duffy (2005) 
advises that if there is a commitment to NSOMExs, there should be concerted effort: 
5 to 10 exercise periods each day, with exercises done in 5 sets of 10 repetitions each, 
3 to 5 times per session.  From limited data, Robertson (2001) reported that patients 
whose dysarthria scores improved less carried out less home practice. There are 
however practical issues, not least patient compliance. Robertson’s (2001) research 
protocol had included three practice sessions each day, but the maximum achieved by 
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individuals was a mean of 2.7, and the participant consensus was that two  practice 
sessions per day would be more realistically achievable.  
 
In the current research, there were no indications of a relationship between the 
regimes adopted and therapists’ belief that they had evidence of efficacy.  The 
questionnaire asked about typical practice and did not seek information as to whether 
type or regime of exercise varied across dysarthria classes, severities, or causative 
neurological disorders. This would have considerably complicated the questionnaire, 
which may have negatively affected response rate. This information might be further 
explored through individual interviews or focus groups. The variation in practice 
amongst respondents underscores the need for investigative work where there is a 
control of potentially influencing variables, such as numbers of exercises and 
repetitions, frequency of practice and length of practice periods.  
 
Conclusion 
That NSOMExs are appropriate in dysarthria is part of the folklore of SLT, and 
folklore may be a potent influence, even impeding the adoption of approaches which 
have scientific validity, in favour of what is handed down by word of mouth, or 
demonstration (Geary 2005). Rosenbek and Jones (2009) refer to there being for SLTs 
a ‘historic predilection’ (P282) to use NSOMExs. Tradition was a reason for exercise 
use for 45% of the relevant respondents, and for 44%, observing the practice of other 
therapists was influential. Furthermore it appears that behaviour is influenced by a 
public presumption that exercises will be given, in that 51% of the respondents using 
NSOMExs gave patient expectations and 25% gave carer expectations, as a rationale 
for use.  
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 For many reasons, including, but not confined to, education, the experience of 
practice, observation, discussion with colleagues, and patient and carer pressure, the 
consensus of opinion would appear to be that non-speech oro-motor exercises have a 
place in dysarthria management, especially in stroke, and flaccid conditions. Whether 
this is justified requires to be assessed, and the high number of respondents who 
indicated interest in being informed about future research plans is encouraging. It is  
only through the results of well controlled research, which compares  outcomes for 
people with dysarthria who receive NSOMExs as part of their SLT management, and 
those who do not, that clinicians may be able to set aside folklore in favour of more 
convincing rationales for using NSOMExs. Alternatively they might be persuaded 
that such exercises are inappropriate in the management of acquired dysarthria. 
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 What this paper adds 
Non-speech oro-motor exercises are reported to be widely used in dysarthria 
intervention. This paper highlights the divergence of opinions about the relevance for 
speech of these exercises, and the absence of robust evidence which would guide 
clinical practice.  
 
A survey of practice and opinions of 191 speech and language therapists revealed that 
non-speech oro-motor exercises are used in acquired dysarthria by 81% of 
respondents, with a wide variety of neurological disorders, diagnostic classes and 
severities. Those who use, and those who do not use, exercises are guided by similar 
rationales, including the opinion that they have evidence from their own practice to 
support their approach  The study provides a justification and foundation for clinical 
research comparing outcomes for people whose dysarthria management includes and 
does not include non-speech oro-motor exercises.   
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Appendix 1a) 
Stages of dysarthria 
 
Improving 
Severity of dysarthria has reduced from an earlier presentation but symptoms are not 
resolved. 
 
Stable 
Severity of dysarthria is now relatively unchanging. 
 
Progressive  
Symptoms of dysarthria may continue to progress and/or new symptoms may appear. 
 
 
Appendix 1b) 
Severities of dysarthria 
 
Mild 
Dysarthria is noticeable but intelligibility is unaffected. Speech rate is essentially 
normal. 
 
Moderate 
Speech is intelligible but rate and naturalness are reduced. 
 
Severe 
Natural speech is the primary means of communication, although it is not completely 
understood in all situations. Speech rate and naturalness are markedly affected. 
 
Profound 
Natural speech may serve some communicative functions, such as greetings or 
response to questions, but intelligibility is markedly reduced. Function is maintained 
by supplementing natural speech with other modes of communication. 
 
Anarthria 
No useful speech.  
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Table 1. Non-speech oro-motor exercise use in dysarthria, dysphagia and 
apraxia of speech (N = 191) 
 
 Respondents Dysphagia: 
yes 
AOS: yes Dysphagia:  
no 
AOS: no 
Dysarthria 
yes 
154 140 62 9 84 
Dysarthria 
no 
37 25 6 10 29 
Totals 191 165 68 19 113 
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Table 2.  Clinical outcome aims in non-speech oro-motor exercise use 
(Respondents  = 146) 
 
Themes Total 
comments 
Comment examples (Respondent number) 
Speech 90 Either maintenance or improvement in 
intelligibility in functional setting.  (R106) 
Improve oral skills and therefore transfer into 
speech skills. (R045) 
Movement 56 
Increase strength, range and speed of 
movements of oro-motor structures. (R105) 
Maintenance and/or improvement in tone, 
strength and accuracy of oral movements. 
(R066) 
Sensory 
awareness 
25 
Maintain/ improve sensation  (R155) 
 
Increase proprioceptive awareness. (R177) 
Appearance  20 
Improved appearance – improved tone in facial 
muscles. (R100) 
Improved facial animation. (R186) 
Emotional 
status 
22 
Involving client in managing their own 
condition can further increase motivation. 
(R94) 
Reduction in the impact of dysarthria on the 
person’s life. (R087) 
Dysphagia and 
drooling 
31 
Improved bolus control and co-ordination in 
feeding. (R165) 
Improved chewing, management of food in the 
mouth, improved swallow. (R117) 
Miscellaneous 03 
Promoting reduction of oedema. (R031) 
 
Maintain oral hygiene (R187) 
Better co-ordination of laryngeal 
muscles/respiration. (R121) 
Total comments 247  
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Figure 1 
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Figure 2 
 
Neurological conditions: % NSOMExs user respondents
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Figure 3  
 
Dysarthria types: % NSOMExs user respondents
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Figure 4 
 
Articulatory structures: frequency of use of NSOMExs
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Figure 5a) 
 
Exercise regimes: Repetitions per exercise: 
% NSOMExs respondents (N = 139)
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Figure 5b)  
 
Exercise regimes: Practice periods per day: % 
NSOMExs respondents (N =141)
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Figure 5c) 
 
Exercise regimes: Minutes per practice 
session: % NSOMExs respondents (N = 145)
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